[Cholecystokinin and vasoactive intestinal polypeptide (VIP) in the central nervous system].
D000818:Animals; D001921:Brain / Q000502:physiology*; D002560:Cerebrovascular Circulation; D002766:Cholecystokinin / Q000502:physiology* / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006729:Hormones, Ectopic / Q000502:physiology; D006801:Humans; D018377:Neurotransmitter Agents / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy; D010903:Pituitary Gland, Anterior / Q000502:physiology; D012528:Satiety Response / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy; D014660:Vasoactive Intestinal Peptide / Q000502:physiology*
D006728:Hormones; D006729:Hormones, Ectopic; D018377:Neurotransmitter Agents; D014660:Vasoactive Intestinal Peptide; D002766:Cholecystokinin
Cholecystokinina i wazoaktywny polipeptyd jelitowy (VIP) w ośrodkowym układzie nerwowym.